These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6148980)

  • 41. 2-(4'-aminobenzenamine)-pyrimidine, a new alpha-antagonist from Autonoë madeirensis.
    Dias C; Paulo A; Nascimento J; Houghton P; Hawkes JE; Gonçalves ML
    Planta Med; 2003 Nov; 69(11):1060-2. PubMed ID: 14735449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. alpha(1)- and alpha(2)-Adrenoceptor hyporesponsiveness in isolated bisected vas deferens of bile duct-ligated rats.
    Heydari F; Mehr SE; Samini M
    Auton Autacoid Pharmacol; 2010 Jul; 30(3):193-6. PubMed ID: 20345427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. alpha-Adrenoceptor stimulated lymphocytes trigger the mechanical response of vas deferens: participation of arachidonic acid metabolites.
    Borda ES; de Bracco MM; Cangiani S; Finiasz M; Sterin-Borda L
    Br J Pharmacol; 1984 Aug; 82(4):863-70. PubMed ID: 6148116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further investigations on the alpha 1-adrenoceptor blocking properties of AR-C 239 in rats.
    Huchet AM; Andréjak M; Lucet B; Gautret B; Doursout MF; Ostermann G; Schmitt H
    Clin Exp Pharmacol Physiol; 1985; 12(5):505-13. PubMed ID: 2867845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced alpha2A-autoreceptor reserve for clonidine induced by reserpine and cholinomimetic agents in the rat vas deferens.
    Pineda J; Ugedo L; García-Sevilla JA
    Br J Pharmacol; 1997 Nov; 122(5):833-40. PubMed ID: 9384498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of prazosin and phentolamine on responses to field stimulation and to noradrenaline in vas deferens and anococcygeus muscle of the rat.
    Doggrell SA; Paton DM
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):209-20. PubMed ID: 686912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the rat.
    Doxey JC; Gadie B; Lane AC; Tulloch IF
    Br J Pharmacol; 1983 Sep; 80(1):155-61. PubMed ID: 6140052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Blocking actions of l-stephanine, xylopine and 7 other tetrahydroisoquinoline alkaloids on alpha adrenoceptors].
    Liu GQ; Han BY; Wang EH
    Zhongguo Yao Li Xue Bao; 1989 Jul; 10(4):302-6. PubMed ID: 2576175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The classical competitive antagonism of phentolamine on smooth muscle preparations, investigated by two procedures.
    Patil PN
    Auton Autacoid Pharmacol; 2007 Jan; 27(1):71-7. PubMed ID: 17199878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological actions of ifenprodil in the rat isolated anococcygeus muscle.
    Adeagbo AS; Magbagbeola AO
    J Pharm Pharmacol; 1985 Nov; 37(11):833-5. PubMed ID: 2867171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of raubasine stereoisomers on pre- and postsynaptic alpha-adrenoceptors in the rat vas deferens.
    Demichel P; Roquebert J
    Br J Pharmacol; 1984 Oct; 83(2):505-10. PubMed ID: 6091834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An investigation of presynaptic alpha-adrenoceptor subtypes in the pithed rat heart and in the rat isolated vas deferens.
    Docherty JR
    Br J Pharmacol; 1984 May; 82(1):15-23. PubMed ID: 6145465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha(1D)-adrenoceptors mediate nerve and agonist-evoked contractions in mouse vas deferens: evidence obtained from knockout technology.
    Bexis S; Cleary L; McGrath JC; Tanoue A; Tsujimoto G; Docherty JR
    Auton Autacoid Pharmacol; 2008; 28(2-3):81-5. PubMed ID: 18598289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Further sub-classification of alpha-adrenoceptors in the cardiovascular system, vas deferens and anococcygeus of the rat [proceedings].
    Docherty JR; MacDonald A; McGrath JC
    Br J Pharmacol; 1979 Nov; 67(3):421P-422P. PubMed ID: 227515
    [No Abstract]   [Full Text] [Related]  

  • 55. Further studies on receptor interaction for the alpha-antagonist WB 4101.
    Kapur H; Green PN; Mottram DR
    J Pharm Pharmacol; 1979 Mar; 31(3):188-9. PubMed ID: 34700
    [No Abstract]   [Full Text] [Related]  

  • 56. On the assessment of the potency of antagonists using the rat isolated anococcygeus muscle.
    Doggrell SA
    J Pharmacol Methods; 1983 Dec; 10(4):243-54. PubMed ID: 6142985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity relationships for 2-substituted imidazoles as alpha 2-adrenoceptor antagonists.
    Caroon JM; Clark RD; Kluge AF; Olah R; Repke DB; Unger SH; Michel AD; Whiting RL
    J Med Chem; 1982 Jun; 25(6):666-70. PubMed ID: 6124635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of cross-desensitization between structurally dissimilar alpha-adrenoceptor agonists.
    Ruffolo RR; Turowski BS; Patil PN
    J Pharm Pharmacol; 1977 Jun; 29(6):378-80. PubMed ID: 18582
    [No Abstract]   [Full Text] [Related]  

  • 59. Dualism in the alpha-adrenoceptor blocking action of dihydroergocristine.
    Lucchelli A; Zonta F; Grana E; Turba C; Pagella P
    Pharmacol Res Commun; 1981 Mar; 13(3):231-40. PubMed ID: 6111090
    [No Abstract]   [Full Text] [Related]  

  • 60. Biogenic amines and morphine responses in the rat vas deferens.
    Miranda H; Rosselot F; Vergara JF; Fernandez E; Larrain G
    Gen Pharmacol; 1981; 12(5):331-4. PubMed ID: 7197244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.